VNL1 Stock Chart & Stats
€0.03
<€0.01(7.69%)
At close: 4:00 PM EST
€0.03
<€0.01(7.69%)
Day’s Range― - ―
52-Week Range<€0.01 - €0.04
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€8.87M
Enterprise Value€52.71
Total Cash (Recent Filing)€25.16M
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)―
Beta-0.25
Next Earnings
Mar 30, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding995,351,700
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)2.36
Price to Sales (P/S)4.69
P/FCF Ratio14.47
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Debt-Free Balance SheetA debt-free structure reduces interest burden, refinancing exposure and financial distress risk. This gives China Health Group greater flexibility to fund operations and pursue recovery initiatives while profitability remains under pressure.
Improved Cash GenerationPositive operating and free cash flow indicates improved cash discipline despite accounting losses. Sustained internal cash generation could support ongoing operations without relying heavily on debt or external financing.
Gross Margin RecoveryThe sharp gross-margin improvement suggests better product economics or business mix. If maintained, it can strengthen contribution margins and provide a foundation for operating leverage, although costs still need to be controlled.
Bears Say
Persistent UnprofitabilityMulti-year losses and deeply negative net margins indicate that the operating model is not yet converting revenue into sustainable earnings. Continued losses can constrain reinvestment, weaken resilience and require a credible turnaround.
Eroding Capital BaseRepeated losses are reducing the company’s equity base and producing negative returns on shareholder capital. This weakens balance-sheet capacity over time, even without debt, and raises the importance of restoring profitability.
Volatile Free Cash FlowAlthough cash flow recently turned positive, the steep year-over-year decline and prior periods of negative operating cash flow show inconsistent conversion. This volatility increases execution risk and may limit dependable self-funding.
VNL1 FAQ
What was China Health Group Inc.’s price range in the past 12 months?
China Health Group Inc. lowest stock price was <€0.01 and its highest was €0.04 in the past 12 months.
What is China Health Group Inc.’s market cap?
China Health Group Inc.’s market cap is €8.87M.
When is China Health Group Inc.’s upcoming earnings report date?
China Health Group Inc.’s upcoming earnings report date is Mar 30, 2027 which is in 213 days.
How were China Health Group Inc.’s earnings last quarter?
China Health Group Inc. released its earnings results on Aug 27, 2026. The company reported €0.001 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.
Is China Health Group Inc. overvalued?
According to Wall Street analysts China Health Group Inc.’s price is currently Overvalued.
Does China Health Group Inc. pay dividends?
China Health Group Inc. does not currently pay dividends.
What is China Health Group Inc.’s EPS estimate?
China Health Group Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does China Health Group Inc. have?
China Health Group Inc. has 995,351,700 shares outstanding.
What happened to China Health Group Inc.’s price movement after its last earnings report?
China Health Group Inc. reported an EPS of €0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of China Health Group Inc.?
Currently, no hedge funds are holding shares in DE:VNL1
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
China Health Group Inc.
China Health Group Inc., an investment holding company, researches and develops drugs, bio drugs, natural drugs, and synthetic drugs in the People’s Republic of China. The company offers contracted pharmaceutical development and clinical research, and post market; and post launch market research, medical science, and medical market services. It also provides hospital management, clinical research and promotion, rehabilitation tourism, and specialty hospital services, as well as Wanquan cloud health services. In addition, the company offers pharmacodynamics and clinical research of drugs. China Health Group Inc. was formerly known as Venturepharm Laboratories Limited and changed its name to China Health Group Inc. in January 2015. The company was founded in 1998 and is headquartered in Beijing, China.
Technical Analysis
Hangzhou Tigermed Consulting Co., Ltd. Class H
―
WuXi AppTec Co., Ltd. Class H
―
JOINN Laboratories (China) Co., Ltd. Class H
―
Mega Genomics Limited
―
Biosino Bio-Technology & Science, Inc. Class H
―